Ovary removal can reduce risk of breast and ovarian cancer in women with gene mutationsBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7349.1295 (Published 01 June 2002) Cite this as: BMJ 2002;324:1295
- Scott Gottlieb
- New York
Women who have the gene mutations BRCA1 or BRCA2 can reduce their likelihood of developing ovarian cancer and breast cancer by having prophylactic surgery to remove both ovaries, according to two new studies in the New England Journal of Medicine.
However, because removing both ovaries substantially lowers the production of hormones, the researchers said there is some concern that hormone replacement therapy—which is required after the surgery—could raise the risk of cancer by restoring some of these hormones.
Previous studies showed that women who carry the BRCA1 or BRCA2 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial